Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Italy
Summary - Voluntary Notice For Preventive Transparency Pursuant To Art. 76 Paragraph 2 Letter B), Point 2 Of Legislative Decree 36/2023, For The Awarding Of The Annual Supply Of Biosimilar Drugs With Active Ingredients: Adalimumab And Etanercept For The Pharmaceutical Department Of The Asl Caserta.
Deadline - Feb 26, 2025
GT reference number - 103135270
Product classification - Office and computing machinery, equipment and supplies except furniture and software packages
Address - Italy
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 103135270
Document Type - Tender Notices
Description - notice_title: Voluntary Notice For Preventive Transparency Pursuant To Art. 76 Paragraph 2 Letter B), Point 2 Of Legislative Decree 36/2023, For The Awarding Of The Annual Supply Of Biosimilar Drugs With Active Ingredients: Adalimumab And Etanercept For The Pharmaceutical Department Of The Asl Caserta.local title:: Avviso volontario per la trasparenza preventiva ai sensi dell’art. 76 comma 2 lett. b), punto 2 del D.lgs. 36/2023, per l’affidamento della fornitura annuale di farmaci biosimilari con principi attivi: ADALIMUMAB e ETANERCEPT per il Dipartimento Farmaceutico dell’Asl Caserta.Contract Type: : SupplyNet Budget Euro: : 716781.07Net Budget LC: : 716781.07 est_amount: 716781.07
Gt Ref Id - 103135270
Deadline - Feb 26, 2025
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database